Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.107EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.243EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
R.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.216EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.471EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.420EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.518EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.551EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.207EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.604EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.111EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.619EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.316EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.436EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.543EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.139EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.362EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.265EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.585EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.351EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.95 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.189EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
C.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.545EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.482EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.324EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.322EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.416EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.239EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.375EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.432EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used